Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $68.3000 (3.48%) ($65.0000 - $75.0000) on Mon. Feb. 11, 2013. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 20.93% (three month average) | RSI | 56 | Latest Price | $68.3000(3.48%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 2.8% a day on average for past five trading days. | Weekly Trend | CAPR advances 3.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(5%) IWM(4%) EWP(3%) XAR(3%) XLY(3%) | Factors Impacting CAPR price | CAPR will decline at least -10.465% in a week (0% probabilities). IGOV(-2%) EMHY(-2%) REMX(-1%) EWY(-1%) XLU(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -10.465% (StdDev 20.93%) | Hourly BBV | 0 () | Intraday Trend | 5.1% | | | |
|
5 Day Moving Average | $61.86(10.41%) | 10 Day Moving Average | $61.03(11.91%) | 20 Day Moving Average | $63.83(7%) | To recent high | -26.2% | To recent low | 425.4% | Market Cap | $1.345b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |